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Aims
To examine the local prevalence of hypokalemia in
patients with diabetic ketoacidosis (DKA), both at pre-
sentation and during treatment, and to investigate the
potential risk factors leading to significant hypokalemia
during treatment of DKA.
Methods
Retrospective review of 114 consecutive patient-epi-
sodes. Univariate analyses were performed to study any
difference in mean between the group with nadir of
potassium (Kn) >= 3.0mmol/L from group with Kn <
3.0mmol/L for predictors concerning patients’ demo-
graphics, the baseline characteristics, the therapies for
DKA (including average insulin infusion rate before Kn),
and the pace of recovery from DKA. Predictors deemed
statistical significant in univariate analyses were sub-
jected to multivariate analysis.
Results
The period prevalence of hypokalemia at presentation
and during treatment of DKA were 13.8% and 92.5%
respectively. Univariate analysis showed patients who
were younger, with lower mean body weight, lower mean
plasma bicarbonate at presentation, lower mean serum
potassium level at presentation, higher urine output per
unit body weight (in the first 24 hours of admission),
higher amount of potassium supplement given before
Kn, shorter time lag of starting potassium supplements
(as reference to time of start of insulin) and longer dura-
tion of metabolic acidosis were independently associated
with risk of developing Kn < 3.0mmol/L. Multivariate
analysis showed that duration of metabolic acidosis was
the sole risk factor for having Kn < 3.0mmol/L.
Conclusions
In our cohort, the longer duration of metabolic acidosis
predicts significant hypokalemia during DKA treatment,
which could have represented a persistent accumulation
of free fatty acid and an on-going stimulus for aldoster-
one secretion, hence kaliuresis-related hypokalemia [1-7].
Therefore, in patients with slow resolution of metabolic
acidosis, the measurement of the urinary potassium
might allow for better estimation of potassium require-
ment during DKA treatment, such that significant hypo-
kalemia could be minimized. In our data, the average
insulin infusion rate was not associated with statistically
increased risk of significant hypokalemia, therefore, the
strategy of lowering insulin infusion rate in patients with
significant hypokalemia during DKA treatment should
require further evaluation.
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